Page last updated: 2024-08-26

fulvestrant and Cancer of Cervix

fulvestrant has been researched along with Cancer of Cervix in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chung, SH; Lambert, PF	1
Cerbón, M; García-López, P; Mohar-Betancourt, A; Pérez-Cárdenas, E; Rodríguez-Dorantes, M	1

Other Studies

2 other study(ies) available for fulvestrant and Cancer of Cervix

Article	Year
Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists. Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-17, Volume: 106, Issue:46 Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Mice; Mice, Transgenic; Papillomavirus Infections; Raloxifene Hydrochloride; Uterine Cervical Neoplasms	2009
Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines. Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6 Topics: Antineoplastic Agents; Carcinoma; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Flow Cytometry; Formazans; Fulvestrant; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Uterine Cervical Neoplasms	2004

Article

Year

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-17, Volume: 106, Issue:46

Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Mice; Mice, Transgenic; Papillomavirus Infections; Raloxifene Hydrochloride; Uterine Cervical Neoplasms

2009

Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.

Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:6

Topics: Antineoplastic Agents; Carcinoma; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Flow Cytometry; Formazans; Fulvestrant; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Uterine Cervical Neoplasms

2004